Blood levels of a protein called sCD40L may serve as a biomarker to track lung complications in patients with cystic…
Joana Fernandes, PhD
Joana brings more than 8 years of academic research and experience as well as Scientific writing and editing to her role as a Science and Research writer. She also served as a Postdoctoral Researcher at the Center for Neuroscience and Cell Biology in Coimbra, Portugal, where she also received her PhD in Health Science and Technologies, with a specialty in Molecular and Cellular Biology.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Joana Fernandes, PhD
Mortality rates among cystic fibrosis (CF) patients in the United States have significantly decreased during the past decade, but hospitalizations and in-hospital…
A recent study reported experiences and perceptions among parents whose children have been diagnosed with cystic fibrosis (CF) or sickle cell…
A Phase 1 clinical trial will evaluate the safety and tolerability of GLPG2737 as a possible treatment for cystic fibrosis…
Several factors may worsen lung infections caused by the bacteria Staphylococcus aureus in cystic fibrosis (CF) patients, from bacterial load to co-infections,…
People interested in knowing more about gene editing and its therapeutic applications can now download a document prepared by the…
Researchers have found that a “swimming” movement by Pseudomonas aeruginosa, the bacteria most commonly associated with lung infections in cystic…
Children diagnosed with cystic fibrosis (CF) months after their birth have worse clinical outcomes than those diagnosed as newborns, a study reports.
Children with cystic fibrosis (CF) who carry the F508del mutation in both CFTR gene copies showed improved lung function after…
#NACFC2016 – RELiZORB Improves Fat Absorption, Gastrointestinal Symptoms in CF Feeding Tube Patients
Alcresta Therapeutics announced that its product RELiZORB effectively increased fat absorption in cystic fibrosis (CF) patients receiving enteral tube feeding…